Accretion Nutraveda Limited (BOM:544694)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Manufacturing and Sale of Pharmaceutical Products	336.15M	160.02M	50.69M	30.03M	5.85M
Total	336.15M	160.02M	50.69M	30.03M	5.85M

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India	334.84M	154.62M	49.12M	28.85M	5.85M
Export	1.20M	5.40M	934.00K	178.00K	-
Total	336.03M	160.02M	50.05M	29.03M	5.85M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error